Zurueck zur Suche

Reporte zur Charge UJ875 AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

21Reporte angezeigt
0Todesfaelle
4Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 5 OH 3 CA 3 NY 2 VA 1 IL 1 DC 1 PA 1 TN 1 MN 1 KS 1 AZ 1

VAERS 2603383

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ875AA

kritisch
Staat
MI
Alter
73,0
Geschlecht
M
Eingang
24.03.2023
Impfdatum
26.10.2022
Beginn
07.03.2023
Tage bis Beginn
132,0
Dosis
N/A
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute respiratory failure Atelectasis Bradycardia Bronchial secretion retention COVID-19 Chest X-ray abnormal Computerised tomogram thorax abnormal Cough Decreased appetite Dyspnoea Haemoglobin decreased Lung consolidation Oropharyngeal pain Pneumonitis Procalcitonin normal SARS-CoV-2 test positive

Symptomtext

Discharge Provider: MD Primary Care Provider: MD Admission Date: 3/7/2023 Discharge Date: Mar 10, 2023 PRESENTING PROBLEM: Hypoxia [R09.02] Acute respiratory failure with hypoxia COVID-19 HOSPITAL COURSE: Patient is a 73 y.o. male with a past medical history of essential tremor, chronic back pain with implanted morphine pump, non insulin-dependent type 2 diabetes and depression who presents today with cough, dyspnea and anorexia. Symptoms started on 02/27. The patient states that it started with a sore throat and cough. In the ER the patient was noted to be hypoxic on room air with an SpO2 of 87%. He remained hypoxic on nasal cannula and required non-rebreather with 15 L of oxygen. He did receive an albuterol inhaler and 6 mg of Decadron. He was able to be weaned down to 6 L by nasal cannula. His other vital signs were unremarkable. Labs significant for hemoglobin 12.7. Procalcitonin was negative. Viral PCR positive for COVID-19. Chest x-ray with new mild left basilar atelectasis or pneumonitis. CTA thorax showed mucous plugging w consolidation. Pt was started on remdsivir and decadron. 02 req improved and after 48 hrs was on 3L. On the 3rd day he was able to be weaned off 02. Labs and VS stable throughout stay. Did become bradycardic in the 30's, believe it was due to remdesivir and this was discontinued. Stable for discharge on 3/10. Discharged with decadron to finish 10 day course.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Non-toxic multinodular goiter Hashimoto's disease End of battery life of intrathecal infusion pump Chronic pain Diabetes mellitus Tobacco dependence Disabling essential tremor Depression COVID-19
Andere Medikamente
Calcium Carb-Cholecalciferol 600-200 MG-UNIT TABS Cholecalciferol 1000 units CAPS clonazepam (KLONOPIN) 1 MG tablet docusate (COLACE) 100 MG capsule EPINEPHrine (EPIPEN) 0.3 MG/0.3ML escitalopram (LEXAPRO) 20 MG tablet metFORMIN (GLUCOPHAGE
Allergien
Shellfish AllergyHives LatexItching Topamax [Topiramate]Hives TrazodoneHives
Vorherige Impfungen
-

VAERS 2498104

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ875AA

schwer
Staat
NY
Alter
72,0
Geschlecht
M
Eingang
15.11.2022
Impfdatum
26.09.2022
Beginn
01.10.2022
Tage bis Beginn
5,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Balance disorder Gait inability Guillain-Barre syndrome Lumbar puncture abnormal Mobility decreased Lumbar puncture Magnetic resonance imaging Vaccination site pain Motor dysfunction Muscular weakness Neck pain Neuralgia Pain Pain in extremity

Symptomtext

guillain barre syndrome; prolonged injection site pain, sharp, shooting pain in both arms; Initial information received on 04-Nov-2022 regarding an unsolicited valid serious case received via consumer/non-hcp (doctor daughter) and doctor. This case involves a 72-year-old male patient who experienced Guillain barre syndrome and prolonged injection site pain, sharp, shooting pain in both arms after receiving vaccines Moderna COVID-19 vaccine and Influenza Quadrival A-B High Dose HV Vaccine [Fluzone High-Dose Quadrivalent]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. This case is linked to case 2022SA462123(same reporter). On 26-Sep-2022, the patient received suspect Fluzone High-Dose Quadrivalent vaccine at dose 0.7 ml once (lot: UJ875AA) via unknown route in the right arm for immunization. On 26-Sep-2022, the patient received a booster dose of suspect MODERNA COVID-19 VACCINE not produced by at (unknown: formulation, strength, dose, lot number not reported via unknown route) in the left arm for immunization. On unknown date in Oct-2022, at 2 weeks latency after vaccination of Fluzone High-Dose Quadrivalent vaccine and MODERNA COVID-19 VACCINE, the patient developed a non-serious prolonged injection site pain described as sharp, shooting pain in both arms (vaccination site pain). The patient was hospitalized on 16-Oct-2022. On 17-Oct-2022 the patient was diagnosed with a serious Guillain barre syndrome (Guillain-Barre syndrome) both at 22 days latency following the administration of Fluzone High-Dose Quadrivalent vaccine and MODERNA COVID-19 VACCINE. This event was assessed as medically significant. The patient was already hospitalized when the event occurred and still in the hospital. Action taken: Fluzone High-Dose Quadrivalent and MODERNA COVID-19 VACCINE was not applicable. It was not reported if the patient received a corrective treatment for the events. At time of reporting, the outcome was Not Recovered for both events.; Sender's Comments: company comment 14-Oct-2022: This case involves a 72-year-old male patient who experienced Guillain barre syndrome and prolonged injection site pain, sharp, shooting pain in both arms after vaccination with Fluzone High-Dose Quadrivalent. Furthermore, information regarding condition at the time of vaccination, role of medical history, concomitants, lab data excluding other predisposing etiologies would be needed for complete assessment of the case. The role of co-suspect Moderna COVID-19 vaccine could be confounder in case. Based upon the reported information, the role of an individual vaccine cannot be assessed.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Guillain-Barre syndrome
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2504308

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ875AA

schwer
Staat
MI
Alter
78,0
Geschlecht
M
Eingang
10.11.2022
Impfdatum
03.11.2022
Beginn
04.11.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Seizure

Symptomtext

Patient came into the pharmacy today to state that he received a flu shot from our pharmacy last Thursday (11/3/22). He stated that he had a seizure the night of 11/4/22 and that the flu shot is the only change in his life (in his 78 years). His doctor informed him to come to the pharmacy so we could file a report. Patient received Fluzone High Dose.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
allergy to penicillin is the only medical history we have on file.
Vorherige Impfungen
-

VAERS 2641110

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ875AA

moderat
Staat
MI
Alter
69,0
Geschlecht
M
Eingang
05.06.2023
Impfdatum
26.09.2022
Beginn
13.05.2023
Tage bis Beginn
229,0
Dosis
N/A
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Akinesia Anticoagulant therapy Asthenia Atrial flutter COVID-19 Cardioversion Chest X-ray normal Echocardiogram Echocardiogram abnormal Ejection fraction decreased Fall Gait inability Laboratory test normal SARS-CoV-2 test positive Supraventricular tachycardia

Symptomtext

5/13/2023 - 5/19/2023 (6 days) DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Generalized weakness Fall, initial encounter COVID-19 virus infection COVID-19 HOSPITAL COURSE: Patient is a 70 y.o. male with a PMHx of DM type II, Depression, GERD and hx of gastric ulcers who presented to the ED due to weakness. In the ED, vitals signs and labs were stable. CXR without acute process. Resp film array resulted positive for COVID-19. He was unable to ambulate in ED therefore requested admission for placement. On admission he remained stable from a respiratory standpoint. During admission he was noted to have SVT. This was not corrected with vagal maneuvers or adenosine. Cardiology was consulted and patient underwent TEE with cardioversion. Suspected underlying rhythm was aflutter with RVR. Eliquis was started. He was also noted to have reduced ejection fraction during procedure so limited echo was repeated before discharge. Limited echo showing EF 40% with akinesis. Cardiology recommended a repeat limited echo in 1 month, 2 week Ziopatch and he was continued on Eliquis. He was seen by PT/OT who recommended home with home health and therapies. He was discharged in medically stable condition.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Supraventricular tachycardia
Hospital-Tage
6,0
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Type 2 diabetes mellitus with neurologic complication, with long-term current use of insulin Essential hypertension GERD (gastroesophageal reflux disease) Depression Obesity Hyperlipidemia History of esophageal stricture with dilatation Blepharospasm syndrome Ulnar impingement syndrome, left Esophageal stricture Esophagitis Normocytic anemia CAD (coronary artery disease) Peripheral vascular disease, unspecified COVID-19
Andere Medikamente
acetaminophen (TYLENOL) 500 MG tablet albuterol (PROVENTIL, VENTOLIN, PROAIR) 108 (90 Base) MCG/ACT inhaler apixaban (ELIQUIS) 5 MG tablet atorvastatin (LIPITOR) 40 mg tablet B-D UF III MINI PEN NEEDLES DULoxetine (CYMBALTA) 60 MG delayed
Allergien
Oxycontin [Oxycodone]Swelling, Rash
Vorherige Impfungen
-

VAERS 2566852

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ875AA

moderat
Staat
MI
Alter
82,0
Geschlecht
F
Eingang
24.01.2023
Impfdatum
18.10.2022
Beginn
16.01.2023
Tage bis Beginn
90,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia Back pain Blood creatinine increased Blood culture COVID-19 Chest X-ray normal Computerised tomogram head normal Cough Fall Fatigue Head injury Laboratory test Mobility decreased Pyrexia SARS-CoV-2 test positive Spinal X-ray normal White blood cell count increased

Symptomtext

Discharge Provider: DO Primary Care Provider: MD Admission Date: 1/16/2023 Discharge Date: Jan 19, 2023 COVID positive date: 1/16/2023 PRESENTING PROBLEM: COVID-19 [U07.1] HOSPITAL COURSE: Patient is a 82 y.o. female with past medical history of hypertension, hyperlipidemia, Parkinson's disease, non-insulin-dependent diabetes with peripheral neuropathy, CKD 3 and benign essential tremor, presented to ED due to generalized weakness and inability to get out of her recliner. She sustained a fall hitting her head and was unable to get up. EMS was summoned and she declined to present to ED. Spent day resting in her recliner and when she attempted to get up was unable to, so EMS was again summoned and brought her to ED. She reported 2-3 days of nonproductive cough, had fever per EMS. Patient has chronic fatigue. Patient reported intermittent weakness due to Parkinson's disease but was able to get around in her house with help of walker. Patient has fallen twice in past 6 months per her husband. Patient has chronic back pain which is unchanged from baseline. Patient also noted lower extremity swelling which is chronic and unchanged. In ED she was febrile to 38.5. Remainder of VSS on RA. Labs with creatinine 1.11, WBC 11.74, LA 1.0. COVID+. Blood cultures were drawn. CT head and CXR unremarkable. She was given 500ml IVF and Tylenol. Patient was admitted with generalized weakness secondary to COVID19. Patient started complaining of acute back pain. X-rays of the spine were done which showed no acute abnormalities. Patient was given 1 time dose of IV Dilaudid which resulted in hallucinations. IV Dilaudid was discontinued and patient was given oral oxycodone for better pain control. Patient was also given Flexeril and provided with heat packs. Physical therapy and occupational therapy were consulted and recommended patient return home with home health care. Pt. will continue with her home tramadol and lidocaine patches for her back pain. Pt. to follow up with her PCP outpatient. She is discharging in improved and stable condition.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Hypertension associated with diabetes Morbid obesity with BMI of 40.0-44.9, adult Gastroesophageal reflux disease without esophagitis Constipation, unspecified constipation type Type 2 diabetes mellitus with diabetic neuropathy, without long-term current use of insulin Peripheral neuropathy Chronic pain of left knee Parkinsonism, unspecified Parkinsonism type OAB (overactive bladder) Detrusor instability of bladder Stage 3a chronic kidney disease Hyperlipidemia associated with type 2 diabetes mellitus Hypothyroidism (acquired) Primary insomnia Generalized weakness Mild depression, active, no psychosis GAD (generalized anxiety disorder) Rotator cuff tear Abnormal EKG Urinary incontinence without sensory awareness Difficulty walking Abnormality of gait Physical deconditioning Tremor
Andere Medikamente
acetaminophen (TYLENOL) 500 MG tablet ALPRAZolam (XANAX) 0.25 MG tablet amLODIPine (NORVASC) 5 MG tablet carbidopa-levodopa (SINEMET) 25-100 MG per tablet escitalopram (LEXAPRO) 20 MG tablet ezetimibe (ZETIA) 10 MG tablet glipiZIDE (GLUCOTR
Allergien
Lincomycin [Lincomycin] Neurontin [Gabapentin] Zithromax [Azithromycin] Levaquin Metformin Vesicare [Solifenacin Ciprofloxacin Clarithromycin Clindamycin Sulfadiazine Sulfamethoxazole W-trimethoprim Trimethoprim Cefaclor Pravastatin Simvastatin
Vorherige Impfungen
-

VAERS 2475883

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj875aa

moderat
Staat
VA
Alter
71,0
Geschlecht
F
Eingang
12.10.2022
Impfdatum
06.10.2022
Beginn
06.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Hypertension

Symptomtext

Systemic: Hypertension-Mild, Additional Details: patient had acute hypertension 90 minutes after vaccine. not sure if related but wanted to report. went to er and they gave her meds to calm and bring down bp. only lasted a few hours

Weitere VAERSDATA-Felder
Praegender Schweregrund
Hypertension
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2472763

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ875AA

moderat
Staat
MI
Alter
75,0
Geschlecht
F
Eingang
09.10.2022
Impfdatum
04.10.2022
Beginn
04.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site inflammation Injection site pruritus Injection site warmth Paraesthesia Pruritus Rash

Symptomtext

Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Additional Details: Pt came in stating the area under her injection site on the left arm (about 2 to 3 inches below the injection site) was red and itchy starting last night. She showed me the area and it was about three inches in diameter and well below the injection site. It was red and inflamed looking and felt warm to the touch. I advised the pt to check with her dr office or an urgent care. Will follow up with the patient to check on how she is doing.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2613214

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ875AA

mild
Staat
OH
Alter
66,0
Geschlecht
F
Eingang
11.04.2023
Impfdatum
06.09.2022
Beginn
28.03.2023
Tage bis Beginn
203,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
COVID-19 Dysgeusia Fatigue Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

3/28/2023 03:00 fatigue, chest congestion, runny nose. Tested with at home COVID-19 test, positive. Televisit with doctor who prescribed PAXLOVID and to treat symptomatically. That afternoon the PAXLOVID caused blood pressure to drop, and there was a very bitter taste in the mouth. After the 5-day course of PAXLOVID, I felt much better. There is a little chest congestion lingering at time of reporting.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
28Mar2023 at home COVID-19 test, positive
Aktuelle Erkrankungen
N/A
Vorgeschichte
Type 2 Diabetes
Andere Medikamente
Verapamil; RABELAIS; metformin; SYNTHROID; VESICARE; lisinopril; liothyronine; atorvastatin; low dose aspirin; probiotic; cranberry pill; iron supplement; multivitamin
Allergien
Mineral oil; BACTRIM; NEOSPORIN; ZOSTAVAX (shingles vaccine); TRULICITY
Vorherige Impfungen
Shingles vaccine, ZOSTAVAX. Injection site reaction, a large and red reaction at the site. 55 2012; All 5 COVID-19 vaccines left

VAERS 2603859

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ875 AA

mild
Staat
IL
Alter
67,0
Geschlecht
F
Eingang
26.03.2023
Impfdatum
13.09.2022
Beginn
16.01.2023
Tage bis Beginn
125,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
COVID-19 Fatigue Influenza like illness SARS-CoV-2 test Vaccine breakthrough infection

Symptomtext

NOTHING AT THE TIME. BREAKTHROUGH COVID IN JAN 2023. FLU LIKE SYMPTOMS FOR A DAY OR TWO. TIREDNESS.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
COVID TEST
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
RALOXIPHENE, VITAMIND3, calcium +D, zinc
Allergien
NONE
Vorherige Impfungen
-

VAERS 2557591

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj875aa

mild
Staat
DC
Alter
70,0
Geschlecht
M
Eingang
11.01.2023
Impfdatum
05.11.2022
Beginn
05.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site bruising Product storage error

Symptomtext

Site: Bruising at Injection Site-Mild, Additional Details: vaccine refrigerator temperature outside the recommended range

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site bruising
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2498116

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ875AA

mild
Staat
OH
Alter
65,0
Geschlecht
F
Eingang
03.11.2022
Impfdatum
16.09.2022
Beginn
16.09.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Joint range of motion decreased Pain

Symptomtext

This patient received a flu vaccine 9/16/22. Since administration, she states she has had decreased range of motion to left arm. She complains of pain with motion of left arm. She reports that symptoms are unchanging over the last 10 weeks. PRN ice has not helped. Pt was advised to follow up with her PCP asap for further evaluation and treatment.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2493338

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ875AA

mild
Staat
PA
Alter
76,0
Geschlecht
M
Eingang
29.10.2022
Impfdatum
24.10.2022
Beginn
24.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration Injection site bruising

Symptomtext

Vaccination appears to have accidentally been done intradermally based on post vaccine bruising and location of injection.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site bruising
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2472765

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ875AA

mild
Staat
TN
Alter
80,0
Geschlecht
F
Eingang
09.10.2022
Impfdatum
28.09.2022
Beginn
03.10.2022
Tage bis Beginn
5,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site inflammation Injection site pruritus Injection site swelling

Symptomtext

Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Additional Details: patient called on 10/5/22 and said she received her flu vaccine on 9/28/22 and on 10/03/22, her arm below the injection site was red, inflamed, and itchy. She is out of town but I told her to keep an eye on it and see a doctor if it did not improve. not sure if its vaccine related, but patient was concerned so i recommended she see a doctor to get it checked out

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2468176

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj875aa

mild
Staat
CA
Alter
76,0
Geschlecht
F
Eingang
04.10.2022
Impfdatum
02.09.2022
Beginn
29.09.2022
Tage bis Beginn
27,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain

Symptomtext

Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2451074

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj875aa

mild
Staat
NY
Alter
81,0
Geschlecht
F
Eingang
15.09.2022
Impfdatum
09.09.2022
Beginn
10.09.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Injection site erythema Injection site swelling

Symptomtext

Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: Patient went to urgent care to see dr.. she states she has had a reaction to a flu shot a couple years ago and thinks it must be an egg sensitivity

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2446090

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ875AA

mild
Staat
MN
Alter
82,0
Geschlecht
F
Eingang
15.09.2022
Impfdatum
26.08.2022
Beginn
26.08.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site pain

Symptomtext

Site: Pain at Injection Site-Medium

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2442528

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ875AA

mild
Staat
KS
Alter
73,0
Geschlecht
F
Eingang
13.09.2022
Impfdatum
05.09.2022
Beginn
05.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site induration Injection site pain Injection site rash Injection site reaction Injection site swelling Injection site warmth Insomnia Nausea Rash Rash papular Urticaria

Symptomtext

Site: Pain at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Nausea-Mild, Systemic: Unable to Sleep-Medium, Additional Details: Hot and hard raised area at localized injection site. Got large round red welt on same inner arm (not injection site) with a darker center that is also raisted.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site induration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2556290

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ875AA

gering
Staat
CA
Alter
71,0
Geschlecht
F
Eingang
10.01.2023
Impfdatum
23.09.2022
Beginn
17.10.2022
Tage bis Beginn
24,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
COVID-19 Cough Rhinorrhoea SARS-CoV-2 test positive Sneezing

Symptomtext

Rather sudden onset of sneezing, runny nose, and coughing. Temperature was 99.9 degrees. Pulse was 111. Oxygen level fluctuated between 84% and 94%. I took Tylenol.

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
17OCT2022 - COVID-19 at home test - positive
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
Calcium; Vitamin D3
Allergien
N/A
Vorherige Impfungen
-

VAERS 2468362

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ875AA

gering
Staat
OH
Alter
73,0
Geschlecht
M
Eingang
04.10.2022
Impfdatum
09.09.2022
Beginn
20.09.2022
Tage bis Beginn
11,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Bradycardia Cardiac pacemaker insertion Catheterisation cardiac Echocardiogram Electrocardiogram

Symptomtext

Bradycardia, but no symptoms. Onset on 9/20/22. Problem resolved after pacemaker placed 9/23/22

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bradycardia
Hospital-Tage
-
Labordaten
Multiple ECGs on 9/21/22; left heart cath 9/22/22; Echocardiogram 9/23/22; pacemaker placement 9/23/22
Aktuelle Erkrankungen
none
Vorgeschichte
hypertension, obesity, GERD
Andere Medikamente
I also received a high dose influenza vaccine at the ame time as the Covid booster. I developed complete heart block with a heart rate of < 50. I had no symptoms, and I was alerted by my Watch. I was seen at a local urgent care clinic, th
Allergien
none
Vorherige Impfungen
-

VAERS 2461878

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ875AA

gering
Staat
AZ
Alter
71,0
Geschlecht
M
Eingang
27.09.2022
Impfdatum
26.09.2022
Beginn
27.09.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Face oedema

Symptomtext

facial edema (left side of lip/ cheek) recommended Benadryl and to report to md asap for further consult. pt pt since sx onset at 4am her saw some improvement

Weitere VAERSDATA-Felder
Praegender Schweregrund
Face oedema
Hospital-Tage
-
Labordaten
TBD
Aktuelle Erkrankungen
none disclosed
Vorgeschichte
none disclosed
Andere Medikamente
none disclosed
Allergien
none disclosed
Vorherige Impfungen
-

VAERS 2429758

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ875AA

gering
Staat
CA
Alter
61,0
Geschlecht
F
Eingang
06.09.2022
Impfdatum
06.09.2022
Beginn
06.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product administered to patient of inappropriate age

Symptomtext

flu clinic given at senior assisted living and care facility advisor instructed all patients over 65 and patient verbal confirmation when applicable but patient was actually 61 years old and was given HD FLUZONE

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-